Evidence map›Paper›PMID 40070300›Full record

ArticleEuropean journal of heart failure2025

Quality of life in heart failure. The heart of the matter. A scientific statement of the Heart Failure Association and the European Association of Preventive Cardiology of the European Society of Cardiology.

Maurizio Volterrani, Geza Halasz, Stamatis Adamopoulos, Pier Giuseppe Agostoni, Javed Butler, Andrew J S Coats, Alan Cohen-Solal, Wolfram Doehner, Gerasimos Filippatos, Ewa Jankowska and 12 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in European journal of heart failure, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Maurizio VolterraniIRCCS San Raffaele Roma, Rome, Italy.
Geza HalaszAzienda Ospedaliera San Camillo-Forlanini, Rome, Italy.
Stamatis AdamopoulosOnassion Hospital, Athens, Greece.
Pier Giuseppe AgostoniCentro Cardiologico Monzino, IRCCS, Milan, Italy.
Javed ButlerBaylor Scott and White Research Institute, Dallas, Texas, USA.
Andrew J S CoatsHeart Research Institute, Sydney, New South Wales, Australia.
Alan Cohen-SolalUniversite Paris Cité, Paris, France.
Wolfram DoehnerBerlin Insititute of Health Center for Regenerative Therapies, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Gerasimos FilippatosDepartment of Cardiology, Attikon University Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
Ewa JankowskaUniversity of Wroclaw, Wroclaw, Poland.
Carolyn S P LamNational Heart Centre Singapore, Singapore, Singapore.
Ekaterini LambrinouCyprus University of Technology, Limassol, Cyprus.
Lars H LundDepartment of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
Giuseppe RosanoSan Raffaele Cassino Hospital, Cassino, Italy.
Marco MetraCardiology, Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, Brescia, Italy.
Stefania PaolilloDepartment of Advanced Biomedical Sciences, Federico II University, Naples, Italy.
Pasquale Perrone FilardiDepartment of Advanced Biomedical Sciences, Federico II University, Naples, Italy.
Amina RakishevaCardiology Department, Scientific Institute of Cardiology and Internal Medicine, Almaty, Kazakhstan.
Gianluigi SavareseDepartment of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
Petar SeferovicUniversity Faculty of Medicine, University of Belgrade, Belgrade, Serbia.
Carlo Gabriele TocchettiDepartment of Translational Medical Sciences (DISMET), Center for Basic and Clinical Immunology Research (CISI), Interdepartmental Center for Clinical and Translational Research (CIRCET), Interdepartmental Hypertension Research Center (CIRIAPA), Federico II University, Naples, Italy.
Massimo PiepoliClinical Cardiology, IRCCS Policlinico San Donato, Milan, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

For most patients with chronic, progressive illnesses, maintaining good quality of life (QoL), with preserved functional capacity, is just as crucial as prolonging survival. Patients with heart failure (HF) experience much worse QoL and effort intolerance than both the general population and people with other chronic conditions, since they present a range of physical and psychological symptoms, including shortness of breath, chest discomfort, fatigue, fluid congestion, trouble with sleeping, and depression. These symptoms reduce patients' capacity for daily social and physical activity. Usual endpoints of large-scale trials in chronic HF have mostly been defined to evaluate treatments regarding hospitalizations and mortality, but more recently, patients' priorities and needs expressed with QoL are gaining more awareness and are being more extensively evaluated. This scientific statement aims at discussing the importance of QoL in HF, summarizing the most largely adopted questionnaires in HF care, and providing an overview on their application in trials and the potential for their transition to clinical practice. Finally, by discussing the reasons limiting their application in daily clinical routine and the strategies that may promote their implementation, this statement aims at fostering the systematic integration of the patient's standpoint in HF care.

Indexed as

CardiologyHeart FailureQuality of LifeSocieties, MedicalEuropeHumansSurveys and QuestionnairesAgingChronic diseaseExercise toleranceFrailtyFunctional capacityHeart failurePhysical activityQuality of life

Identifiers

PMID40070300
PMCPMC12370584

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.